Evidence Supporting the Use of Cephalosporin Antibiotics in Penicillin-Allergic Patients
Michael E. Pichichero
Abstract
Michael E. Pichichero
Abstract
The objective was to review the frequency of allergic cross-reactivity between penicillins and cephalosporin antibiotics. MEDLINE and EMBASE databases were searched for all English language articles relevant to penicillin and cephalosporin cross-sensitivity. Among 219 retrieved articles, 103 were included in the review. Based on 38 studies, the evidence suggests that the crossreactive, immunoglobulin E (IgE)-mediated immune responses between penicillins and cephalosporins are based on molecular side chain similarities of the antibiotics rather than similarities in β lactam rings. Twenty-eight studies examined 5420 patients with a history of penicillin allergy compared to 47,976 without such a history who received cephalosporins; possible allergic reactions were noted in 138 (2.55%) and 654 (1.36%) patients respectively (p < 0.0001). However, the risk of a cross-allergic reaction occurred predominantly among patients receiving first-generation cephalosporins with related chemical side chains to penicillin or amoxicillin. The proportion of patients with a cross-allergy to a first generation cephalosporin was increased by 6.1% (95% confidence interval [CI] for difference between penicillin allergic and nonallergic = 5.4%–6.9% p < 0.0001) while to second- and third-generation cephalosporins with unrelated chemical side chains, the proportion was decreased by 0.45% (95% CI = –1.2%–0.3%; p = 0.25). Cephalosporin skin testing, described in 21 articles, predicts hypersensitivity to the specific cephalosporin skin test reagents or those with similar side chains and based on 3 studies a positive skin test is 10%–38% predictive of a clinical reaction. Experimental and clinical studies suggest that side-chain–specific antibodies predominate in the allergic immune response to cephalosporins thereby explaining the lack of cross-sensitivity between second- and third-generation cephalosporins and penicillins. (Pediatr Asthma Allergy Immunol 2005; 18[4]:230–246.)
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The objective was to review the frequency of allergic cross-reactivity between penicillins and cephalosporin antibiotics. MEDLINE and EMBASE databases were searched for all English language articles relevant to penicillin and cephalosporin cross-sensitivity. Among 219 retrieved articles, 103 were included in the review. Based on 38 studies, the evidence suggests that the crossreactive, immunoglobulin E (IgE)-mediated immune responses between penicillins and cephalosporins are based on molecular side chain similarities of the antibiotics rather than similarities in β lactam rings. Twenty-eight studies examined 5420 patients with a history of penicillin allergy compared to 47,976 without such a history who received cephalosporins; possible allergic reactions were noted in 138 (2.55%) and 654 (1.36%) patients respectively (p < 0.0001). However, the risk of a cross-allergic reaction occurred predominantly among patients receiving first-generation cephalosporins with related chemical side chains to penicillin or amoxicillin. The proportion of patients with a cross-allergy to a first generation cephalosporin was increased by 6.1% (95% confidence interval [CI] for difference between penicillin allergic and nonallergic = 5.4%–6.9% p < 0.0001) while to second- and third-generation cephalosporins with unrelated chemical side chains, the proportion was decreased by 0.45% (95% CI = –1.2%–0.3%; p = 0.25). Cephalosporin skin testing, described in 21 articles, predicts hypersensitivity to the specific cephalosporin skin test reagents or those with similar side chains and based on 3 studies a positive skin test is 10%–38% predictive of a clinical reaction. Experimental and clinical studies suggest that side-chain–specific antibodies predominate in the allergic immune response to cephalosporins thereby explaining the lack of cross-sensitivity between second- and third-generation cephalosporins and penicillins. (Pediatr Asthma Allergy Immunol 2005; 18[4]:230–246.)
Key concepts: Cephalosporin, Penicillin, Medicine, Antibiotics, Cephalosporin Antibiotic, Amoxicillin, Allergy, Dermatology